Center Publications

Shrestha, Neha, et al. “Endoplasmic Reticulum Protein Quality Control in β Cells”. 2020. Seminars in Cell & Developmental Biology, vol. 103, 2020, pp. 59–67.

Davis, Jeffrey C, et al. “Glucose Response by Stem Cell-Derived β Cells In Vitro Is Inhibited by a Bottleneck in Glycolysis”. 2020. Cell Reports, vol. 31, no. 6, 2020, p. 107623.

Kim, Joon T, et al. “A Plasma Protein Network Regulates PM20D1 and N-Acyl Amino Acid Bioactivity”. 2020. Cell Chemical Biology, vol. 27, no. 9, 2020, pp. 1130–1139.e4.

Jones, Morgan S, et al. “Inpatient Transition to Virtual Care During COVID-19 Pandemic”. 2020. Diabetes Technology & Therapeutics, vol. 22, no. 6, 2020, pp. 444–448.

Maikawa, Caitlin L, et al. “A Co-Formulation of Supramolecularly Stabilized Insulin and Pramlintide Enhances Mealtime Glucagon Suppression in Diabetic Pigs”. 2020. Nature Biomedical Engineering, vol. 4, no. 5, 2020, pp. 507–517.

Peterson, Linda R, et al. “Alterations in Plasma Triglycerides and Ceramides: Links With Cardiac Function in Humans With Type 2 Diabetes”. 2020. Journal of Lipid Research, vol. 61, no. 7, 2020, pp. 1065–1074.

Joffre, Jérémie, et al. “Activation of CBR Promotes Lipopolysaccharide-Induced IL-10 Secretion by Monocytic Myeloid-Derived Suppressive Cells and Reduces Acute Inflammation and Organ Injury”. 2020. Journal of Immunology (Baltimore, Md. : 1950), vol. 204, no. 12, 2020, pp. 3339–3350.

Lu, Geming, et al. “Dextran Sulfate Protects Pancreatic β-Cells, Reduces Autoimmunity and Ameliorates Type 1 Diabetes”. 2020. Diabetes, 2020.

Yamamoto, Keisuke, et al. “Autophagy Promotes Immune Evasion of Pancreatic Cancer by Degrading MHC-I”. 2020. Nature, vol. 581, no. 7806, 2020, pp. 100–105.

Yang, Steven, et al. “Functional Effects of Muscle PGC-1alpha in Aged Animals”. 2020. Skeletal Muscle, vol. 10, no. 1, 2020, p. 14.

Mahadevan, Jana, et al. “A Soluble Endoplasmic Reticulum Factor As Regenerative Therapy for Wolfram Syndrome”. 2020. Laboratory Investigation; A Journal of Technical Methods and Pathology, 2020.

Buse, John B, et al. “Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial”. 2020. Diabetes Care, vol. 43, no. 7, 2020, pp. 1546–1552.